Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study

Critical Care

Research

Ryoto Sakaniwa¹  Yasuharu Tokuda²  Takuhiro Moromizato³  Kenji Shibuya⁴  Kiyosu Taniguchi⁵ 

[1] Department of Social Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan;Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan;Tokyo Foundation for Policy Research, Minato-ku, Tokyo, Japan;Muribushi Okinawa Center for Teaching Hospitals, Urasoe, Okinawa, Japan;Okinawa Nanbu Prefectural Medical Center and Children’s Medical Center, Haebaru, Okinawa, Japan;Tokyo Foundation for Policy Research, Minato-ku, Tokyo, Japan;Tokyo Foundation for Policy Research, Minato-ku, Tokyo, Japan;Tokyo Foundation for Policy Research, Minato-ku, Tokyo, Japan;National Hospital Organization Mie National Hospital, Tsu-shi, Mie, Japan;

关键词: COVID-19;    Steroid pulse therapy;    Critical care;    Mechanical ventilation;    In-hospital mortality;   

DOI  :  10.1186/s13054-023-04337-5

 received in 2022-10-31, accepted in 2023-01-27,  发布年份 2023

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 4

Fig. 1

12302_2023_718_Article_IEq4.gif

Fig. 6